Dynatronics (DYNT) Competitors $0.09 -0.01 (-7.37%) As of 07/14/2025 03:06 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsSEC FilingsShort InterestTrendsBuy This Stock DYNT vs. TTOO, NDRA, XAGE, BJDX, NAOV, BBLG, IVF, LGMK, AVGR, and NUWEShould you be buying Dynatronics stock or one of its competitors? The main competitors of Dynatronics include T2 Biosystems (TTOO), ENDRA Life Sciences (NDRA), Longevity Health (XAGE), Bluejay Diagnostics (BJDX), Nanovibronix (NAOV), Bone Biologics (BBLG), INVO Fertility (IVF), LogicMark (LGMK), Avinger (AVGR), and Nuwellis (NUWE). These companies are all part of the "medical equipment" industry. Dynatronics vs. Its Competitors T2 Biosystems ENDRA Life Sciences Longevity Health Bluejay Diagnostics Nanovibronix Bone Biologics INVO Fertility LogicMark Avinger Nuwellis Dynatronics (NASDAQ:DYNT) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, media sentiment, risk, earnings, profitability, analyst recommendations and valuation. Do institutionals and insiders hold more shares of DYNT or TTOO? 4.2% of Dynatronics shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 8.0% of Dynatronics shares are owned by company insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Do analysts rate DYNT or TTOO? T2 Biosystems has a consensus price target of $5.00, suggesting a potential upside of 4,251.61%. Given T2 Biosystems' stronger consensus rating and higher probable upside, analysts clearly believe T2 Biosystems is more favorable than Dynatronics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Dynatronics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00T2 Biosystems 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Which has stronger earnings & valuation, DYNT or TTOO? Dynatronics has higher revenue and earnings than T2 Biosystems. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDynatronics$33.60M0.03-$2.70M-$0.78-0.11T2 Biosystems$7.68M0.31-$50.08MN/AN/A Is DYNT or TTOO more profitable? Dynatronics has a net margin of -8.35% compared to T2 Biosystems' net margin of -563.16%. T2 Biosystems' return on equity of 0.00% beat Dynatronics' return on equity.Company Net Margins Return on Equity Return on Assets Dynatronics-8.35% -41.81% -9.56% T2 Biosystems -563.16%N/A -174.06% Which has more volatility and risk, DYNT or TTOO? Dynatronics has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, T2 Biosystems has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Does the media favor DYNT or TTOO? In the previous week, Dynatronics' average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score. Company Overall Sentiment Dynatronics Neutral T2 Biosystems Neutral SummaryDynatronics beats T2 Biosystems on 6 of the 11 factors compared between the two stocks. Get Dynatronics News Delivered to You Automatically Sign up to receive the latest news and ratings for DYNT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DYNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DYNT vs. The Competition Export to ExcelMetricDynatronicsSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$935K$59.99M$5.53B$9.30BDividend YieldN/AN/A4.59%4.02%P/E Ratio-0.115.0228.5619.60Price / Sales0.0386.98361.1874.21Price / CashN/A18.4124.7327.56Price / Book0.156.718.155.55Net Income-$2.70M-$24.59M$3.24B$257.73M7 Day PerformanceN/A0.81%2.03%0.95%1 Month PerformanceN/A-6.09%8.29%10.68%1 Year PerformanceN/A20.95%28.40%15.67% Dynatronics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DYNTDynatronicsN/A$0.09-7.4%N/A-46.7%$935K$33.60M-0.11200Gap DownTTOOT2 Biosystems2.295 of 5 stars$0.14-3.6%$5.00+3,603.7%-97.9%$2.84M$7.68M0.00180NDRAENDRA Life Sciences2.9121 of 5 stars$3.46-2.3%$50.00+1,345.1%-99.9%$2.61MN/A-0.0220High Trading VolumeXAGELongevity HealthN/A$2.35-3.7%N/AN/A$2.45M$50K0.0014News CoverageAnalyst DowngradeBJDXBluejay Diagnostics1.2609 of 5 stars$1.63flatN/A-94.7%$2.44MN/A0.009News CoverageNAOVNanovibronix0.3278 of 5 stars$0.92-1.2%N/A-88.7%$2.40M$2.56M-0.0720BBLGBone Biologics0.9082 of 5 stars$3.00-14.0%N/A-60.3%$1.90MN/A0.002Gap DownIVFINVO FertilityN/A$0.81-6.3%N/AN/A$1.87M$6.59M-0.0210Gap DownLGMKLogicMark0.1373 of 5 stars$0.00+13.3%N/A-100.0%$1.73M$9.88M0.0020Gap DownAVGRAvingerN/A$0.47flatN/AN/A$1.57M$7.65M-0.0470NUWENuwellis3.1181 of 5 stars$7.11-13.8%$714.00+9,942.2%-95.9%$860K$8.74M-0.3970News CoverageGap Down Related Companies and Tools Related Companies T2 Biosystems Competitors ENDRA Life Sciences Competitors Longevity Health Competitors Bluejay Diagnostics Competitors Nanovibronix Competitors Bone Biologics Competitors INVO Fertility Competitors LogicMark Competitors Avinger Competitors Nuwellis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DYNT) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dynatronics Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dynatronics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
